George Soros's VRNA Position Overview
George Soros (via Soros Fund Management LLC) currently holds 285,185 shares of Verona Pharma plc (VRNA) worth $30.43 M, representing 0.43% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, George Soros has initiated a new position in VRNA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
George Soros's Verona Pharma plc (VRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Verona Pharma plc (VRNA) Trades by George Soros
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +285,185 | New Buy | 285,185 | $106.71 |
George Soros's Verona Pharma plc Investment FAQs
George Soros first purchased Verona Pharma plc (VRNA) in Q3 2025, acquiring 285,185 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
George Soros has held Verona Pharma plc (VRNA) for 1 quarters since Q3 2025.
George Soros's largest addition to Verona Pharma plc (VRNA) was in Q3 2025, adding 285,185 shares worth $30.43 M.
According to the latest 13F filing for Q3 2025, George Soros's firm, Soros Fund Management LLC, owns 285,185 shares of Verona Pharma plc (VRNA), valued at approximately $30.43 M.
As of the Q3 2025 filing, Verona Pharma plc (VRNA) represents approximately 0.43% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.
George Soros's peak holding in Verona Pharma plc (VRNA) was 285,185 shares, as reported at the end of Q3 2025.